We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Medical Management Tool Helps Combat Influenza A(H1N1)

By HospiMedica International staff writers
Posted on 24 Jul 2009
A new study describes a statistical tool, which could have the power to macro- and micromanage pandemic influenza outbreaks. More...


Researchers at Tel Aviv University (Israel) developed a set of modeling tools that is modular in design; the models are complicated when the existing data is good, but become simpler when key variables are missing. To complement the modeling tools, the researchers are using an extensive database, with over 10 years of combined data collected by a large network of hospital and medical clinics in Israel. The researchers also took into account that influenza A(H1N1) will attack more people than an annual seasonal flu, because most people have only limited immunity to the new influenza A(H1N1). These factors are worked into the model so that communities, hospitals, and bodies like the United Nations (UN) or the U.S. Centers for Disease Control (CDC) can make better decisions in planning. The new model might also be used to understand bio-terror attacks, should such a catastrophic event take place. The researchers hope to have a commercial version of the model available within three years.

"Our model provides guidance for complex decisions such as whether to close airports, schools, and travel routes, and how to distribute Tamiflu,” said lead researcher Professor Lewi Stone, Ph.D., of the department of life sciences at TAU. "It could be applied to very small populations as well as populations as large as 6 to 10 million people and more.”

"Based on our study of influenza outbreaks in Israel,” said Amit Huppert, M.D., of the Tel Hashomer Hospital (Israel), who is collaborating on the research, "we can estimate the rate at which the virus spreads in towns with a very young population. These communities are especially at risk. Communities in the U.S. with a high population of children can be advised to stock up on antivirals.”

Related Links:
Tel Aviv University
Tel Hashomer Hospital



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.